Sweden
· Delayed Price · Currency is SEK Sedana Medical AB Statistics
Total Valuation
Sedana Medical AB has a market cap or net worth of SEK 2.32 billion. The enterprise value is 2.03 billion.
| Market Cap | 2.32B |
| Enterprise Value | 2.03B |
Important Dates
The next estimated earnings date is Thursday, October 24, 2024.
| Earnings Date | Oct 24, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Sedana Medical AB has 99.34 million shares outstanding. The number of shares has increased by 0.49% in one year.
| Shares Outstanding | 99.34M |
| Shares Change (YoY) | +0.49% |
| Shares Change (QoQ) | +9.26% |
| Owned by Insiders (%) | 11.85% |
| Owned by Institutions (%) | 47.92% |
| Float | 66.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.78 |
| PB Ratio | 2.39 |
| P/FCF Ratio | 158.77 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -48.91 |
| EV / Sales | 12.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 138.53 |
Financial Position
The company has a current ratio of 6.30, with a Debt / Equity ratio of 0.81.
| Current Ratio | 6.30 |
| Quick Ratio | 5.44 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.54 |
| Interest Coverage | -262.75 |
Financial Efficiency
Return on equity (ROE) is -4.18% and return on invested capital (ROIC) is -3.53%.
| Return on Equity (ROE) | -4.18% |
| Return on Assets (ROA) | -3.37% |
| Return on Capital (ROIC) | -3.53% |
| Revenue Per Employee | 2.08M |
| Profits Per Employee | -511,975 |
| Employee Count | 79 |
| Asset Turnover | 0.16 |
| Inventory Turnover | 1.19 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.12% in the last 52 weeks. The beta is 0.25, so Sedana Medical AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +21.12% |
| 50-Day Moving Average | 23.94 |
| 200-Day Moving Average | 21.11 |
| Relative Strength Index (RSI) | 50.86 |
| Average Volume (20 Days) | 95,376 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sedana Medical AB had revenue of SEK 168.68 million and -41.47 million in losses. Loss per share was -0.42.
| Revenue | 168.68M |
| Gross Profit | 118.62M |
| Operating Income | -56.49M |
| Pretax Income | -40.79M |
| Net Income | -41.47M |
| EBITDA | -54.62M |
| EBIT | -56.49M |
| Loss Per Share | -0.42 |
Balance Sheet
The company has 304.22 million in cash and 7.90 million in debt, giving a net cash position of 296.32 million or 2.98 per share.
| Cash & Cash Equivalents | 304.22M |
| Total Debt | 7.90M |
| Net Cash | 296.32M |
| Net Cash Per Share | 2.98 |
| Equity (Book Value) | 972.22M |
| Book Value Per Share | 9.79 |
| Working Capital | 318.81M |
Cash Flow
In the last 12 months, operating cash flow was 15.18 million and capital expenditures -535,000, giving a free cash flow of 14.64 million.
| Operating Cash Flow | 15.18M |
| Capital Expenditures | -535,000 |
| Free Cash Flow | 14.64M |
| FCF Per Share | 0.15 |
Margins
Gross margin is 70.32%, with operating and profit margins of -33.49% and -24.59%.
| Gross Margin | 70.32% |
| Operating Margin | -33.49% |
| Pretax Margin | -24.18% |
| Profit Margin | -24.59% |
| EBITDA Margin | -32.38% |
| EBIT Margin | -33.49% |
| FCF Margin | 8.68% |
Dividends & Yields
Sedana Medical AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.49% |
| Shareholder Yield | -0.49% |
| Earnings Yield | -1.79% |
| FCF Yield | 0.63% |
Stock Splits
The last stock split was on May 26, 2021. It was a forward split with a ratio of 4.
| Last Split Date | May 26, 2021 |
| Split Type | Forward |
| Split Ratio | 4 |